Both ECRG4 and OGN function as tumor suppressors in the bladder, with ECRG4 overexpression inhibiting NF-kB signaling and promoting NFIC/OGN signaling in bladder cancer cells (55). This evidence concerns the gene OGN and urinary bladder cancer.